tiprankstipranks
Editas Medicine Inc (EDIT)
NASDAQ:EDIT

Editas Medicine (EDIT) Financial Statements

3,162 Followers

Editas Medicine Financial Overview

Editas Medicine's market cap is currently ―. The company's EPS TTM is $-2.102; its P/E ratio is -2.38; Editas Medicine is scheduled to report earnings on July 31, 2024, and the estimated EPS forecast is $-0.70. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 1.14M$ 60.05M$ 5.34M$ 2.89M$ 9.85M
Gross Profit$ 1.14M$ 60.05M$ 5.34M$ 2.89M$ 9.85M
EBIT$ -66.99M$ -23.96M$ -45.02M$ -40.29M$ -49.04M
EBITDA$ -65.58M$ -22.50M$ -46.23M$ -38.75M$ -47.49M
Net Income Common Stockholders$ -61.95M$ -18.87M$ -45.02M$ -40.29M$ -49.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 296.17M$ 323.11M$ 349.62M$ 431.97M$ 318.44M
Total Assets$ 440.34M$ 499.15M$ 504.65M$ 541.95M$ 464.11M
Total Debt$ 34.14M$ 36.54M$ 34.61M$ 37.19M$ 37.14M
Net Debt$ -262.03M$ -286.57M$ -315.01M$ -394.78M$ -281.30M
Total Liabilities$ 145.95M$ 150.06M$ 144.19M$ 142.04M$ 146.63M
Stockholders Equity$ 287.70M$ 349.10M$ 360.46M$ 399.92M$ 317.47M
Cash Flow-
Free Cash Flow$ -51.74M$ -23.55M$ -35.70M$ -40.04M$ -37.61M
Operating Cash Flow$ -49.87M$ -22.24M$ -35.46M$ -38.71M$ -35.77M
Investing Cash Flow$ -4.75M$ 62.84M$ -102.82M$ 12.98M$ 23.27M
Financing Cash Flow$ 192.00K$ 514.00K-$ 117.53M-
Currency in USD

Editas Medicine Earnings and Revenue History

Editas Medicine Debt to Assets

Editas Medicine Cash Flow

Editas Medicine Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis